EU: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the EU

The EU human and animal blood market surged to $X in 2021, jumping by X% against the previous year. The total consumption indicated a prominent expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, consumption increased by +X% against 2015 indices. Over the period under review, the market hit record highs in 2021 and is likely to see steady growth in years to come.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in the EU

In value terms, human and animal blood production skyrocketed to $X in 2021 estimated in export price. Overall, production showed a strong increase. The pace of growth appeared the most rapid in 2018 with an increase of X% against the previous year. As a result, production reached the peak level of $X. From 2019 to 2021, production growth failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in the EU

Human and animal blood exports surged to X tons in 2021, with an increase of X% against the previous year. Total exports indicated resilient growth from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2014 indices. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports skyrocketed to $X in 2021. Over the period under review, exports recorded buoyant growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

In 2021, France (X tons), distantly followed by Denmark (X tons), Germany (X tons), the Netherlands (X tons), Italy (X tons) and Spain (X tons) were the largest exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together constituting X% of total exports. Poland (X tons) followed a long way behind the leaders.

From 2012 to 2021, the biggest increases were in the Netherlands (with a CAGR of +X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, Germany ($X), France ($X) and Denmark ($X) constituted the countries with the highest levels of exports in 2021, with a combined X% share of total exports. The Netherlands, Italy, Poland and Spain lagged somewhat behind, together accounting for a further X terms of the main exporting countries, the Netherlands, with a CAGR of +X%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2021, the export price in the European Union amounted to $X per ton, growing by X% against the previous year. Export price indicated a resilient expansion from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood export price increased by +X% against 2019 indices. As a result, the export price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2021, the country with the highest price was Germany ($X per ton), while Spain ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by France (+X%), while the other leaders experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in the EU

For the third consecutive year, the European Union recorded growth in overseas purchases of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, which increased by X% to X tons in 2021. Total imports indicated a prominent expansion from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2014 indices. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, imports hit record highs in 2021 and are likely to continue growth in years to come.

In value terms, human and animal blood imports skyrocketed to $X in 2021. In general, imports showed resilient growth. The pace of growth appeared the most rapid in 2020 when imports increased by X% against the previous year. Over the period under review, imports reached the maximum in 2021 and are expected to retain growth in years to come.

Imports by Country

In 2021, France (X tons), distantly followed by Germany (X tons), the Netherlands (X tons), Denmark (X tons), Austria (X tons), Belgium (X tons), Spain (X tons), Italy (X tons), Sweden (X tons) and Poland (X tons) were the main importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together creating X% of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by France (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood importing markets in the European Union were Germany ($X), France ($X) and Italy ($X), with a combined X% share of total imports.

Among the main importing countries, France, with a CAGR of +X%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the import price in the European Union amounted to $X per ton, increasing by X% against the previous year. Import price indicated a tangible increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood import price increased by +X% against 2015 indices. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2021, the country with the highest price was Italy ($X per ton), while Austria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :